Preview

Rational Pharmacotherapy in Cardiology

Advanced search

EFFECT OF SIMVASTATIN ON THE PROGNOSIS AND THE CHANGES OF THE CLINICAL STATUS IN PATIENTS WITH ACUTE ISCHEMIC STROKE. THE RESULTS OF THE 12 MONTH RANDOMIZED, OPEN COMPARATIVE STUDY

https://doi.org/10.20996/1819-6446-2013-9-4-379-385

Full Text:

Abstract

Aim. To evaluate in open 12 month prospective, randomized study the mortality and recurrent cardiovascular events rate, dynamics of neurological deficit, endothelial dysfunc- tion and renal function in patients with the first ischemic stroke of hemispheric localization after prescription of simvastatin 40 mg daily in the acute stage of the disease. Material and methods. Patients (n=210) above 18 years of age (95 men and 115 women) with acute ischemic stroke were included into the study. Patients were randomized into two groups. Patients of the group 1 (n=105) received standard treatment for ischemic stroke. Patients of the group 2 (n=105) received simvastatin 40 mg/day additional- ly to standard therapy of stroke. Follow-up duration was 12 months. The lipid profile, a number of desquamated epithelial cells circulating in the blood, glomerular filtration rate (GFR) according to MDRD, as well as neurological patient status (Scandinavian Scale, MMSE, NIHSS) were monitored.
Results. During the follow-up period mortality was 18.1% and 15.2% in group 1 and 2, respectively. Composite end point was achieved in 60.9% and 46.6% of patients, re- spectively (p=0.037). Lipid profile did not change significantly in group 1 while patients in group 2 showed a significant decrease in lipid levels. The positive dynamics of neuro- logical status was observed in both groups, however, the most significant - in group 2. Reduction in a number of endothelial desquamated cells was 45.7% in group 2 and 13.3% in group 1 (p=0.00001). GFR increased significantly in patients of group 2.
Conclusion. The long-term treatment with simvastatin in combination with neuroprotective and antihypertensive therapy in patients with acute ischemic stroke leads to decrease in the incidence rate of clinically relevant events, improvement of endothelial function, neurological status and prognosis.

About the Authors

V. V. Yakusevich
Yaroslavl State Medical Academy, Yaroslavl
Russian Federation


A. Yu. Malygin
City Clinical Hospital № 8, Yaroslavl
Russian Federation


A. V. Kabanov
Yaroslavl State Medical Academy, Yaroslavl
Russian Federation


References

1. Drapkina OM Brain stroke: a view of the therapeutic window. Consilium Medicum 2011, 13 (10): 119–22. Russian (Драпкина О.М. Мозговой инсульт: взгляд из терапевтического окна. Consilium Medicum 2011; 13(10): 119–22)

2. Kotova O.V. Prevention of stroke: undocumented features. Russian Journal of Medicine 2012; (10): 514. Russian (Котова О.В. Профилактика инсультов: неучтенные возможности. Русский Медицинский Журнал 2012; (10): 514)

3. Suslina ZA. Vascular disease of the brain in Russia: Reality and perspectives on the problem. Materials XIIІ International Conference "Current trends in neurology", 27–29 April 2011, Sudak (Ukraine). Sudak, 2011. Russian (Суслина З.А. Сосудистые заболевания головного мозга в России: реальность и перспективы решения проблемы. Материалы XIIІ Международной конференции «Актуальные направления в неврологии», 27–29 апреля 2011, Судак (Украина). Судак; 2011).

4. Fonyakin AV Geraskina LA Current strategies of secondary prevention of ischemic stroke. Consilium Medicum 2011, (2) :17–22. Russian (Фонякин А. В., Гераскина Л. А. Современные стратегии вторичной профилактики ишемического инсульта. Consilium Medicum 2011; (2):17–22)

5. Isaykin AI Pathogenic aspects of treatment of ischemic stroke. Difficult Patient 2010; (4): 21–25. Russian (Исайкин А.И. Патогенетические аспекты терапии ишемического инсульта. Трудный Пациент 2010; (4): 21–25)

6. Starodubtseva OS, Begichev SV. Experience in implementation of monitoring of stroke in the metropolis. Modern Problems of Education and Science 2012, (4): http://www.science-education.ru/104–

7. Access Date 23.06.2013. Russian (Стародубцева О.С., Бегичева С.В. Опыт внедрения мониторинга за инсультом в мегаполисе. Современные Проблемы Науки и Образования 2012; (4): http://www.science-education.ru/104–6867. Дата обращения 23.06.2013)

8. Denisova EV. Current epidemiology of cerebrovascular diseases in the world (review). Bulletin of Public Health and Health Care of the Far East of Russia 2011 (3): 1–5. Russian (Денисова Е.В. Актуальные вопросы эпидемиологии сосудистых заболеваний головного мозга в мире (обзор литературы). Вестник Общественного Здоровья и Здравоохранения Дальнего Востока России 2011;(3): 1–5)

9. Demaerschalk BM, Hwang HM, Leung G. US cost burden of ischemic stroke: a systematic literature review. Am J Manag Care 2010;16(7):525–33

10. Suslin ZA, Tanashyan MM, Ionova VG. Ischemic stroke: the blood vessel wall, antithrombotic therapy. Moscow: Medical books; 2005. Russian (Суслина З.А., Танашян М. М., Ионова В. Г. Ишемический инсульт: кровь, сосудистая стенка, антитромботическая терапия. М.: Медицинска Книга; 2005).

11. Voloshin PV, Malakhov, VA, AN Zavgorodnyaya Endothelial dysfunction in cerebrovascular disease. Kharkov: KhMAPE, 2006. Russian (Волошин П.В., Малахов В.А., Завгородняя А.Н. Эндотелиальная дисфункция при цереброваскулярной патологии. Харьков: ХМАПО; 2006).

12. Golovchenko YI, Treschinskaya MA. Pathogenetic features of local regulation of cerebral circulation in endothelial dysfunction. Materials XIIІ International Conference "Current trends in neurology", 27–

13. April 2011, Sudak (Ukraine). Sudak, 2011. Russian (Головченко Ю.И., Трещинская М.А. Патогенетические особенности локальной регуляции мозгового кровообращения при эндотелиальной дисфункции. Материалы XIIІ Международной конференции «Актуальные направления в неврологии», 27–29 апреля 2011, Судак (Украина). Судак; 2011).

14. Domashenko M.A. The evaluation of endothelial dysfunction in ischemic cerebrovascular diseases. European Journal of Neurology 2006; 13 (Suppl 2): 182

15. Lupinskaya ZA, Zarifyan AG, Gurovich TT, Shleifer SG. The endothelium. Function and dysfunction. Bishkek: KRSU; 2008. Russian (Лупинская З.А, Зарифьян А.Г., Гурович Т.Ц., Шлейфер С.Г. Эндотелий. Функция и дисфункция. Бишкек: КРСУ; 2008).

16. Hladovec J. Circulating endothelial cells as a sign of vessel wall lesions. Physiol Bohemoslov 1978;27(2):140–144

17. Mukhin NA. The decrease in glomerular filtration rate — population-wide marker of poor prognosis. Ter Arkhiv 2007; (6):5–10. Russian (Мухин Н.А. Снижение скорости клубочковой фильтрации – общепопуляционный маркер неблагоприятного прогноза. Терапевтический Архив 2007; (6): 5–10).

18. Savustyanenko AV. The use of simvastatin in renal disease. News of Medicine and Pharmacy in 2012, (8): 3–4. Russian (Савустьяненко А.В. Применение симвастатина при заболеваниях почек. Новости Медицины и Фармации 2012; (8): 3–4)

19. Giannopoulos S., Katsanos A.H., Tsivgoulis G., Marshall R.S. Statins and cerebral hemodynamics. J Cereb Blood Flow Metab 2012;32(11):1973–6

20. Moonis M. High-Dose Statins Should Be Used in All Acute Ischemic Strokes. Stroke 2012;43: 1992–3.

21. Squizzato A, Romualdi E, Dentali F, Ageno W. Statins for Acute Ischemic Stroke. Stroke 2012;43: e18–e19

22. Reeves MJ, Kapral M, Fang J et al. Effect of Statin Treatment Before and After Hospitalization on Mortality Following Acute Ischemic Stroke: Importance of Confounding by Stroke Severity and Palliative Care. Stroke 2013;44:A201

23. Gusev EI, Skvortsova VI, Chekneva NS. et al. The treatment of acute stroke (diagnostic and therapeutic algorithms). Moscow: Russian State Medical University; 1997. Russian (Гусев Е.И., Скворцова В.И., Чекнева Н.С. и др. Лечение острого мозгового инсульта (диагностические и терапевтические алгоритмы). М.: РГМУ; 1997).

24. Renal function and prediction of cardiovascular risk. Russian recommendations. Cardiovascular Therapy and Prevention 2008, 7 (3) suppl 3: 1–34. Russian (Функциональное состояние почек и про- гнозирование сердечно-сосудистого риска. Российские рекомендации. Кардиоваскулярная Те- рапия и Профилактика 2008; 7 (3) приложение 3: 1–34).

25. Agueyev FT Nuralyev EY, Chernin GV et al. The controlled use of simvastatin "ordinary" treatment of hyperlipidemia in patients with coronary heart disease in an outpatient setting: a comparative study of the two strategies (TONE CONTROL). Cardiology 2006; (6) :10–5. Russian (Агеев Ф.Т., Нура- лиев Э.Ю., Чернина Г.В. и др. Контролируемое применение симвастатина «обычная» терапия гиперлипидемии у больных с ишемической болезнью сердца в амбулаторных условиях: сравнительное исследование двух стратегий (СИГНАЛ–КОНТРОЛЬ). Кардиология 2006; (6):10–5).

26. Belousov YB, Namsaraev JN. Endothelial dysfunction as a cause of atherosclerotic arteries in hypertension: correction methods. Farmateka 2005; 84 (6): 38–42. Russian (Белоусов Ю.Б., Намсараев Ж.Н. Эндотелиальная дисфункция как причина атеросклеротического поражения артерий при артериальной гипертензии: методы коррекции. Фарматека 2005; 84 (6): 38–42).

27. Thomas A, Poisson S, Johnson SC et al. Level of Renal Function and Short-term Risk of Recurrent Stroke. Stroke 2013; 44: ATMP93

28. Panteleev MA, Ataullakhanov FI. Blood clotting: Contemporary Issues. Clinical Hematology 2008, (3): 259–65. Russian (Пантелеев М.А., Атауллаханов Ф.И. Свертывание крови: современные проблемы. Клиническая Онкогематология 2008; (3): 259—65)

29. Zagidullin NS, Zagidullin SZ. Features of treatment of stroke patients in therapeutic practice. Directory of Outpatient Physician 2010; (8): 29–32. Russian (Загидуллин Н.Ш., Загидуллин Ш.З. Особенности лечения больных, перенесших инсульт, в терапевтической практике. Справочник Поликлинического Врача 2010; (8): 29–32).

30. Nedogoda SV. Features of simvastatin in the treatment of diseases of the cardiovascular system. Directory of Outpatient Physician 2010; (8): 40–43. Russian (Недогода С.В. Возможности симва- статина в лечении заболеваний сердечно-сосудистой системы. Справочник Поликлинического Врача 2010; (8): 40–43).

31. Stakhovskaya LV, Meshkova KS, Shehovtsova KV, Skvortsova VI. Differentiated secondary prevention of stroke: Further to the recommendations. Consilium Medicum 2009; (1): 16–8. Russian (Стаховская Л.В., Мешкова К.С., Шеховцова К.В., Скворцова В.И. Дифференцированная вторичная профилактика инсульта: дополнение к рекомендациям. Consilium Medicum 2009; (1): 16–8).

32. Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated metaanalysis of statins for stroke prevention. The Lancet Neurology 2009; 8(5): 453–63

33. Madden J.A. Role of the vascular endothelium and plaque in acute ischemic stroke. Neurology 2012;79(13 Suppl 1):S58–62.

34. Mather K.J. The vascular endothelium in diabetes-a therapeutic target? Rev Endocr Metab Disord 2013;14(1):87–99

35. Kim JA, Montagnani M, et al. Role of lipotoxicity in endothelial dysfunction. Heart Fail Clin 2012;8(4):589–607

36. Sandhu S., Wiebe N., Fried L.F., Tonelli M. Statins for improving renal outcomes: a metaanalysis. J Am Soc Nephrol 2006;17(7): 2006–16

37. McNeish A.J., Jimenez-Altayo F., Cottrell G.S. et al. Statins and selective inhibition of Rho kinase protect small conductance calcium-activated potassium channel function (K(Ca)2.3) in cerebral arteries. PLoS One 2012;7(10):e46735.

38. Tsukurova LA, Bursa YA. Risk factors, primary and secondary prevention of stroke. Russian Journal of Medicine 2012; (10): 494–500. Russian (Цукурова Л.А., Бурса Ю.А. Факторы риска, первичная и вторичная профилактика острых нарушений мозгового кровообращения. Русский Медицинский Журнал 2012; (10): 494–500)

39. Béjot Y, Zeller M, Lorgis L et al. Secondary prevention in patients with vascular disease. A population based study on the underuse of recommended medications. J Neurol Neurosurg Psychiatry 2013;84(3):348–53

40. Di Legge S, Koch G, Diomedi M et al. Stroke prevention: managing modifiable risk factors. Stroke Res Treat 2012;2012:391538

41. Schepankevich LA, Pylypenko PI. Ischemic stroke: evaluation of the parameters of vascular-platelet hemostasis in acute period of the disease. Bulletin of Neurology, Neurosurgery and Psychiatry, 2011; (1): 11–13. Russian (Щепанкевич Л.А., Пилипенко П.И. Ишемический инсульт: оценка пара- метров сосудисто-тромбоцитарного звена гемостаза в остром периоде заболевания. Вестник Неврологии, Психиатрии и Нейрохирургии 2011; (1): 11–13).

42. Halcox J.P.J., Donald A.E., Ellins E. et al. Endothelial Function Predicts Progression of Carotid IntimaMedia Thickness. Circ 2009; 119; 1005–12.


For citation:


Yakusevich V.V., Malygin A.Yu., Kabanov A.V. EFFECT OF SIMVASTATIN ON THE PROGNOSIS AND THE CHANGES OF THE CLINICAL STATUS IN PATIENTS WITH ACUTE ISCHEMIC STROKE. THE RESULTS OF THE 12 MONTH RANDOMIZED, OPEN COMPARATIVE STUDY. Rational Pharmacotherapy in Cardiology. 2013;9(4):379-385. (In Russ.) https://doi.org/10.20996/1819-6446-2013-9-4-379-385

Views: 497


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)